Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adri C Voogd

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Pathology|March 12, 2014
Chromosome instability predicts progression of premalignant lesions of the larynxVerona E Bergshoeff, Stijn J A Van der Heijden, Annick Haesevoets, et al.
Journal of the National Cancer Institute|April 5, 2017
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young WomenMarjanka K Schmidt, Alexandra J van den Broek, Rob A E M Tollenaar, et al.
The Lancet. Oncology|June 29, 2026
Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry studyAnnefleur J W Mauritz, Linda de Munck, Janine M Simons, et al.
Breast Cancer Research and Treatment|October 10, 2013
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcomeDorien J A Lobbezoo, Roel J W van Kampen, Adri C Voogd, et al.
Annals of Surgery|May 5, 2018
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer PatientsAlexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2023
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancerYuwei Wang, Annegien Broeks, Daniele Giardiello, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2010
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution studyClaudia Allemani, Hans Storm, Adri C Voogd, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2016
Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centersAdam Gondos, Lina Jansen, Jörg Heil, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 13, 2024
Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort studyRobert-Jan Schipper, Anne de Bruijn, Maurice J C van der Sangen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2017
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 yearsEllen G Engelhardt, Alexandra J van den Broek, Sabine C Linn, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Pathology|March 12, 2014
Chromosome instability predicts progression of premalignant lesions of the larynxVerona E Bergshoeff, Stijn J A Van der Heijden, Annick Haesevoets, et al.
Journal of the National Cancer Institute|April 5, 2017
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young WomenMarjanka K Schmidt, Alexandra J van den Broek, Rob A E M Tollenaar, et al.
The Lancet. Oncology|June 29, 2026
Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry studyAnnefleur J W Mauritz, Linda de Munck, Janine M Simons, et al.
Breast Cancer Research and Treatment|October 10, 2013
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcomeDorien J A Lobbezoo, Roel J W van Kampen, Adri C Voogd, et al.
Annals of Surgery|May 5, 2018
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer PatientsAlexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2023
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancerYuwei Wang, Annegien Broeks, Daniele Giardiello, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2010
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution studyClaudia Allemani, Hans Storm, Adri C Voogd, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2016
Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centersAdam Gondos, Lina Jansen, Jörg Heil, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 13, 2024
Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort studyRobert-Jan Schipper, Anne de Bruijn, Maurice J C van der Sangen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2017
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 yearsEllen G Engelhardt, Alexandra J van den Broek, Sabine C Linn, et al.
Pageof 16